Search research articles
Contact Us
Filters
Showing results (11-20 of 189) with videos related to
Page
of 19
Sort By:
Pharmacological Reviews
|
December 13, 2025
Metformin-mechanisms of its glycemia-reducing effect
Jürgen Drewe, Marc Foretz, Stephan Krähenbühl
Nature Reviews. Endocrinology
|
August 24, 2019
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz, Bruno Guigas, Benoit Viollet
Nature Reviews. Endocrinology
|
May 2, 2023
Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoit Viollet
Biochemical Pharmacology
|
February 7, 2018
Promise and challenges for direct small molecule AMPK activators
Séverine Olivier, Marc Foretz, Benoit Viollet
Medecine Sciences : M/S
|
April 7, 2006
[From cancer to diabetes treatment : the tumor suppressor LKB1 as a new pharmacological target]
Marc Foretz, Bruno Guigas, Benoît Viollet
International Journal of Molecular Sciences
|
September 22, 2018
AMPK Activation Reduces Hepatic Lipid Content by Increasing Fat Oxidation In Vivo
Marc Foretz, Patrick C Even, Benoit Viollet
Blood Cells, Molecules & Diseases
|
July 24, 2007
Haptoglobin is degraded by iron in C57BL/6 mice: a possible link with endoplasmic reticulum stress
Audrey Faye, Guillemette Ramey, Marc Foretz, et al.
Scientific Reports
|
October 6, 2017
AMPK is not required for the effect of metformin on the inhibition of BMP6-induced hepcidin gene expression in hepatocytes
Jean-Christophe Deschemin, Marc Foretz, Benoit Viollet, et al.
Clinical Chemistry
|
August 17, 2012
Hepatic peroxisome proliferator-activated receptor γ coactivator 1α and hepcidin are coregulated in fasted/refed states in mice
Jean-Christophe Deschemin, Marc Foretz, Benoit Viollet, et al.
The Journal of Biological Chemistry
|
March 19, 2020
Glucose availability but not changes in pancreatic hormones sensitizes hepatic AMPK activity during nutritional transition in rodents
Camille Huet, Nadia Boudaba, Bruno Guigas, et al.
Page
of 19
Search research articles
Search
Showing results (11-20 of 189) with videos related to
Sort By:
Page
of 19
Pharmacological Reviews
|
December 13, 2025
Metformin-mechanisms of its glycemia-reducing effect
Jürgen Drewe, Marc Foretz, Stephan Krähenbühl
Nature Reviews. Endocrinology
|
August 24, 2019
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Marc Foretz, Bruno Guigas, Benoit Viollet
Nature Reviews. Endocrinology
|
May 2, 2023
Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoit Viollet
Biochemical Pharmacology
|
February 7, 2018
Promise and challenges for direct small molecule AMPK activators
Séverine Olivier, Marc Foretz, Benoit Viollet
Medecine Sciences : M/S
|
April 7, 2006
[From cancer to diabetes treatment : the tumor suppressor LKB1 as a new pharmacological target]
Marc Foretz, Bruno Guigas, Benoît Viollet
International Journal of Molecular Sciences
|
September 22, 2018
AMPK Activation Reduces Hepatic Lipid Content by Increasing Fat Oxidation In Vivo
Marc Foretz, Patrick C Even, Benoit Viollet
Blood Cells, Molecules & Diseases
|
July 24, 2007
Haptoglobin is degraded by iron in C57BL/6 mice: a possible link with endoplasmic reticulum stress
Audrey Faye, Guillemette Ramey, Marc Foretz, et al.
Scientific Reports
|
October 6, 2017
AMPK is not required for the effect of metformin on the inhibition of BMP6-induced hepcidin gene expression in hepatocytes
Jean-Christophe Deschemin, Marc Foretz, Benoit Viollet, et al.
Clinical Chemistry
|
August 17, 2012
Hepatic peroxisome proliferator-activated receptor γ coactivator 1α and hepcidin are coregulated in fasted/refed states in mice
Jean-Christophe Deschemin, Marc Foretz, Benoit Viollet, et al.
The Journal of Biological Chemistry
|
March 19, 2020
Glucose availability but not changes in pancreatic hormones sensitizes hepatic AMPK activity during nutritional transition in rodents
Camille Huet, Nadia Boudaba, Bruno Guigas, et al.
Page
of 19